Point72 Asset Management
IRMD icon

Point72 Asset Management’s iRadimed IRMD Stock Holding History

Point72 Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Buy
14,319
+3,337
+30% +$334K ﹤0.01% 2555
2025
Q4 		$1.07M Sell
10,982
-228
-2% -$19.6K ﹤0.01% 2836
2025
Q3 		$798K Buy
+11,210
New +$747K ﹤0.01% 1779
2023
Q3 		– Sell
-502
Closed -$23.9K – 2665
2023
Q2 		$23.9K Buy
+502
New +$22.6K ﹤0.01% 1754
2016
Q1 		– Sell
-100
Closed -$3K – 782
2015
Q4 		$3K Buy
+100
New +$2.83K ﹤0.01% 664

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's IRMD Position: Q1 2026 in Review

Point72 Asset Management increased its iRadimed (IRMD) stake by 30% in Q1 2026, buying an estimated $334K and bringing the position to 14,319 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Point72 Asset Management first reported a position in IRMD in Q4 2015 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Point72 Asset Management held 14,319 shares of iRadimed worth $1.38M as of Q1 2026.
  • Point72 Asset Management bought 3,337 iRadimed shares in Q1 2026, an estimated $334K.
  • iRadimed made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2555 holding.
  • Point72 Asset Management first reported a position in iRadimed in Q4 2015 and has held it in 5 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.